Pfizer and BioNTech provide update on COVID-19 vaccine supply agreement with European Commission
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028
- Details
- Category: Roche
![Roche Roche](/images/logo/roche.png)
Pfizer to acquire Biohaven Pharmaceuticals
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
Foundation S: Sanofi's new philanthropic spearhead
- Details
- Category: Sanofi
![Sanofi Sanofi](/images/logo/sanofi.png)
Pfizer shares top-line results from Phase 2/3 EPIC-PEP study of PAXLOVID™ for post-exposure prophylactic use
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
SK bioscience and GSK's adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/logo/gsk.png)
Pfizer and Biohaven's VYDURA® (rimegepant) granted first ever marketing authorization by European Commission for both acute treatment of migraine and prophylaxis of episodic migraine
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
More Pharma News ...
- Novartis provides more than USD 25 million in medical aid to patients in Ukraine and bordering countries
- Evusheld significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations
- GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn
- Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board
- Pfizer to acquire ReViral and its respiratory syncytial virus therapeutic candidates
- Novartis announces new organizational structure
- U.S. FDA grants priority review to Roche's Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults